Abnormal involuntary movements after L-dopa treatment in a rat model of striatonigral degeneration (Multiple System Atrophy)

被引:0
|
作者
Stefanova, N
Lundblad, M
Cenci, MA
Poewe, W
Wenning, GK
机构
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
P792
引用
收藏
页码:S246 / S246
页数:1
相关论文
共 50 条
  • [31] Effect of a selective 5-HT1A agonist tandospirone on abnormal involuntary movements in rat L-DOPA-induced dyskinesia model
    Ishibashi, T
    Konishi, O
    Takasugi, N
    Ito, A
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2006, 100 : 192P - 192P
  • [32] Effect of a selective 5-HT1A agonist tandospirone on abnormal involuntary movements in rat L-DOPA-induced dyskinesia model
    Ishibashi, Tadashi
    Konishi, Osamu
    Takasugi, Nobumasa
    Ito, Akira
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2006, 101 : 110 - 110
  • [33] Progressive striatonigral degeneration in a transgenic mouse model of multiple system atrophy: translational implications for interventional therapies
    Refolo, Violetta
    Bez, Francesco
    Polissidis, Alexia
    Kuzdas-Wood, Daniela
    Sturm, Edith
    Kamaratou, Martina
    Poewe, Werner
    Stefanis, Leonidas
    Cenci, M. Angela
    Romero-Ramos, Marina
    Wenning, Gregor K.
    Stefanova, Nadia
    ACTA NEUROPATHOLOGICA COMMUNICATIONS, 2018, 6 : 2
  • [34] Dopaminergic co-transmission with sonic hedgehog inhibits abnormal involuntary movements in models of Parkinson's disease and L-Dopa induced dyskinesia
    Malave, Lauren
    Zuelke, Dustin R.
    Uribe-Cano, Santiago
    Starikov, Lev
    Rebholz, Heike
    Friedman, Eitan
    Qin, Chuan
    Li, Qin
    Bezard, Erwan
    Kottmann, Andreas H.
    COMMUNICATIONS BIOLOGY, 2021, 4 (01)
  • [35] Dopaminergic co-transmission with sonic hedgehog inhibits abnormal involuntary movements in models of Parkinson’s disease and L-Dopa induced dyskinesia
    Lauren Malave
    Dustin R. Zuelke
    Santiago Uribe-Cano
    Lev Starikov
    Heike Rebholz
    Eitan Friedman
    Chuan Qin
    Qin Li
    Erwan Bezard
    Andreas H. Kottmann
    Communications Biology, 4
  • [36] Riluzole Attenuates L-DOPA-Induced Abnormal Involuntary Movements Through Decreasing CREB1 Activity: Insights from a Rat Model
    Luca Pagliaroli
    Joanna Widomska
    Ester Nespoli
    Tobias Hildebrandt
    Csaba Barta
    Jeffrey Glennon
    Bastian Hengerer
    Geert Poelmans
    Molecular Neurobiology, 2019, 56 : 5111 - 5121
  • [37] AMPA antagonists attenuate L-DOPA-induced abnormal involuntary movements in the 6-OHDA-lesioned rat model of Parkinson's disease
    Kobylecki, C.
    Ravenscroft, P.
    Crossman, A.
    PARKINSONISM & RELATED DISORDERS, 2007, 13 : S140 - S140
  • [38] Riluzole Attenuates L-DOPA-Induced Abnormal Involuntary Movements Through Decreasing CREB1 Activity: Insights from a Rat Model
    Pagliaroli, Luca
    Widomska, Joanna
    Nespoli, Ester
    Hildebrandt, Tobias
    Barta, Csaba
    Glennon, Jeffrey
    Hengerer, Bastian
    Poelmans, Geert
    MOLECULAR NEUROBIOLOGY, 2019, 56 (07) : 5111 - 5121
  • [39] RILUZOLE ATTENUATES L-DOPA-INDUCED ABNORMAL INVOLUNTARY MOVEMENTS THROUGH DECREASING CREB1 ACTIVITY: INSIGHTS FROM A RAT MODEL
    Widomska, Joanna
    Pagliaroli, Luca
    Nespoli, Ester
    Hildebrandt, Tobias
    Barta, Csaba
    Glennon, Jeffrey
    Hengerer, Bastian
    Poelmans, Geert
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2019, 29 : 1117 - 1118
  • [40] Striatonigral neurons divide into two distinct morphological-physiological phenotypes after chronic L-DOPA treatment in parkinsonian rats
    Fieblinger, T.
    Zanetti, L.
    Sebastianutto, I.
    Breger, L. S.
    Quintino, L.
    Lockowandt, M.
    Lundberg, C.
    Cenci, M. A.
    SCIENTIFIC REPORTS, 2018, 8